ATE422878T1 - Formulierungen, welche dicht und weniger dicht mit igf-i beladen sind, zur verwendung in multivesikulären liposomen - Google Patents

Formulierungen, welche dicht und weniger dicht mit igf-i beladen sind, zur verwendung in multivesikulären liposomen

Info

Publication number
ATE422878T1
ATE422878T1 AT98945974T AT98945974T ATE422878T1 AT E422878 T1 ATE422878 T1 AT E422878T1 AT 98945974 T AT98945974 T AT 98945974T AT 98945974 T AT98945974 T AT 98945974T AT E422878 T1 ATE422878 T1 AT E422878T1
Authority
AT
Austria
Prior art keywords
igf
mvls
osmolarity
liposomes
aqueous component
Prior art date
Application number
AT98945974T
Other languages
English (en)
Inventor
Bret Shirley
Maninder Hora
Qiang Ye
Nandini Katre
John Asherman
Original Assignee
Skyepharma Inc
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skyepharma Inc, Novartis Vaccines & Diagnostic filed Critical Skyepharma Inc
Application granted granted Critical
Publication of ATE422878T1 publication Critical patent/ATE422878T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98945974T 1997-09-08 1998-09-08 Formulierungen, welche dicht und weniger dicht mit igf-i beladen sind, zur verwendung in multivesikulären liposomen ATE422878T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/925,531 US6306432B1 (en) 1997-09-08 1997-09-08 High and low load formulations of IGF-I in multivesicular liposomes

Publications (1)

Publication Number Publication Date
ATE422878T1 true ATE422878T1 (de) 2009-03-15

Family

ID=25451863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945974T ATE422878T1 (de) 1997-09-08 1998-09-08 Formulierungen, welche dicht und weniger dicht mit igf-i beladen sind, zur verwendung in multivesikulären liposomen

Country Status (9)

Country Link
US (1) US6306432B1 (de)
EP (1) EP1021167B1 (de)
JP (1) JP2001515852A (de)
AT (1) ATE422878T1 (de)
AU (1) AU9310098A (de)
DE (1) DE69840576D1 (de)
ES (1) ES2322974T3 (de)
PT (1) PT1021167E (de)
WO (1) WO1999012522A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2343767T3 (es) 1997-09-18 2010-08-09 Pacira Pharmaceuticals, Inc. Composiciones anestesicas liposomicas de liberacion sostenida.
US7067485B2 (en) * 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
JP4575592B2 (ja) * 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
GB0113179D0 (en) 2001-05-31 2001-07-25 Novartis Ag Organic compounds
US20050118249A1 (en) * 2001-11-13 2005-06-02 Murray Webb Lipid carrier compositions and methods for improved drug retention
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides
JP4515951B2 (ja) * 2005-03-31 2010-08-04 富士通セミコンダクター株式会社 半導体装置及びその製造方法
US8105611B2 (en) * 2005-06-17 2012-01-31 Allergan, Inc. Treatment of autoimmune disorder with a neurotoxin
WO2011127456A2 (en) 2010-04-09 2011-10-13 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9770414B2 (en) * 2010-05-13 2017-09-26 Pacira Pharmaceuticals, Inc. Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
CN103260702B (zh) * 2010-10-28 2018-07-27 帕西拉制药有限公司 非甾体类抗炎药的缓释制剂
ES2634669T3 (es) 2011-02-08 2017-09-28 Halozyme, Inc. Composición y formulación lipídica de una enzima de degradación de hialuronano y uso de la misma para el tratamiento de la hiperplasia benigna de próstata
CN104427976B (zh) 2012-05-10 2018-04-24 佩因拉佛姆有限公司 疏水的活性成分的储库制剂及其制备方法
CN103478707B (zh) * 2013-08-23 2015-04-08 楼秀余 胰岛素样生长因子-ⅰ缓释片及其制备方法
EP3186281B1 (de) 2014-08-28 2019-04-10 Halozyme, Inc. Kombinationstherapie mit einer hyaluronanabbauendem enzym und einem immun-checkpoint-hemmer
MX381655B (es) 2015-05-04 2025-03-13 Versantis AG Metodo para preparar vesiculas con gradiente de ph de transmembrana.
CN109983013A (zh) 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
KR102069680B1 (ko) * 2017-03-02 2020-01-23 단디바이오사이언스 주식회사 면역억제인자 제어물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (de) 1974-07-19 1977-06-15 Battelle Memorial Institute
US4897308A (en) 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4078052A (en) 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
US4086257A (en) 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
CH624011A5 (de) 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4310506A (en) 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
JPS55153713A (en) 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4394372A (en) 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
JPH0768117B2 (ja) * 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
US4599227A (en) 1983-11-07 1986-07-08 Wisconsin Alumni Research Foundation Injectable pharmaceutical preparation for the induction of multiple follicular growth
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
IE58981B1 (en) 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
US5244678A (en) 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
US5173219A (en) * 1986-02-12 1992-12-22 Research Development Foundation Uniform spherical multilamellar liposomes of defined and adjustable size distribution
US5204112A (en) 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US4781871A (en) 1986-09-18 1988-11-01 Liposome Technology, Inc. High-concentration liposome processing method
US4752425A (en) 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US5723147A (en) * 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
GB8704171D0 (en) * 1987-02-23 1987-04-01 Clayton Found Res Multivesicular liposomes
JP2666345B2 (ja) 1987-04-16 1997-10-22 武田薬品工業株式会社 リポソーム製剤およびその製造法
CA1335348C (en) * 1988-03-04 1995-04-25 Yasuaki Ogawa Liposome composition
US5261903A (en) 1988-04-11 1993-11-16 M.D. Inc. Composite anesthetic article and method of use
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
BE1001869A3 (fr) 1988-10-12 1990-04-03 Franz Legros Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
US4921853A (en) 1988-11-14 1990-05-01 Michigan State University Method for producing analgesia in mammals
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5246707A (en) 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US5091187A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5169934A (en) 1990-05-14 1992-12-08 Anergen, Inc. Intracellularly cleavable compounds
USRE35192E (en) 1990-11-13 1996-03-26 Phoenix Surgical Products, Inc. Post-surgical anesthesia at a continuous and progressively decreasing administration rate
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CA2093381A1 (en) * 1992-04-07 1993-10-08 Hideyuki Sawahara Liposome formulation and process for production thereof
WO1994004184A2 (en) * 1992-08-12 1994-03-03 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5321012A (en) 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5451408A (en) 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
US5931809A (en) * 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
JPH09278670A (ja) * 1995-10-06 1997-10-28 Fujisawa Pharmaceut Co Ltd インシュリン様成長因子１の経口投与製剤
US5766027A (en) * 1995-12-21 1998-06-16 The Whitaker Corporation Cable assembly with equalizer board
JPH09194389A (ja) * 1996-01-11 1997-07-29 Fujisawa Pharmaceut Co Ltd ステロイドミオパチー予防・治療剤

Also Published As

Publication number Publication date
US6306432B1 (en) 2001-10-23
AU9310098A (en) 1999-03-29
WO1999012522A1 (en) 1999-03-18
ES2322974T3 (es) 2009-07-02
DE69840576D1 (de) 2009-04-02
PT1021167E (pt) 2009-04-20
EP1021167B1 (de) 2009-02-18
EP1021167A1 (de) 2000-07-26
EP1021167A4 (de) 2003-04-02
JP2001515852A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
DE69840576D1 (de) Formulierungen, welche dicht und weniger dicht mit igf-i beladen sind, zur verwendung in multivesikulären liposomen
ATE356614T1 (de) Veränderung der wirkstoffladung in multivesikulären liposomen
WO2001058474A3 (en) Microencapsulation and sustained release of biologically active agent
DE69614685D1 (de) Mittel zur verzögerten freisetzung von menschlichem wachstumshormon
WO2004047801A3 (en) Method of drug loading in liposomes by gradient
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
MX9709699A (es) Composicion para la liberacion sostenida de eritropoyetina no agregada.
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
GB2290964A (en) Transdermal drug delivery system
ATE265847T1 (de) Selbstemulgierbare formulierung enthaltend lipophile verbindungen
HU908477D0 (en) Process for the production of medical preparations with controlled content of active agents
AU5347596A (en) External preparations for treating dermatoses
AU8645098A (en) Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
NZ515644A (en) Oil-core compositions for the sustained release of hydrophobic drugs
WO1993004691A1 (en) Compositions and methods for treating wounds
YU3101A (sh) Farmaceutska formulacija suspenzije koja obuhvata amoksicilin, klavulonsku kiselinu i celulozu
ES2024668B3 (es) Microparticulas que comportan un polimero biodegradable que controla la liberacion de un principio activo antimalarico, composiciones farmaceuticas que lo contienen y procedimiento de preparacion
ZA200004597B (en) Sustained-release preparation of physiologically active polypeptide and production thereof.
MX9301817A (es) Sistema polimerico que contiene un compuesto parcialmente soluble.
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
FR2748209B1 (fr) Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
EE200200368A (et) Tramadoolvesinikkloriidi sisaldav toimeainet reguleeritult vabastav ravimkoostis ja meetod selle valmistamiseks
SE9902742D0 (sv) New pharmaceutical formultion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1021167

Country of ref document: EP